Comparison of Electronic Surveillance With Routine Monitoring for Patients With Lymphoma at High Risk of Relapse: Prospective Randomized Controlled Phase 3 Trial (Sentinel Lymphoma)

Katell Le Dû   ^{1 *} , MD ;   Adrien Chauchet   ^{2 *} , MD ;   Sophie Sadot-Lebouvier   ^{1 *} , MD ;   Olivier Fitoussi   ^{3 *} , MD ;   Bijou Fontanet   ^{4 *} , MD ;   Arnaud Saint-Lezer   ^{5 *} , MD ;   Frédéric Maloisel   ^{6 *} , MD, PhD ;   Cédric Rossi   ^{7 *} , MD, PhD ;   Sylvain Carras   ^{8 *} , MD ;   Anne Parcelier   ^{9 *} , MD ;   Magali Balavoine   ^{10 *} ;   Anne-Lise Septans   ^{10 *} , PhD

¹ Department of Hematology, Confluent Private Hospital, Nantes, France

² Department of Hematology, University Hospital, Besançon, France

³ Department of Hematology, Polyclinique Bordeaux Nord Aquitaine, Bordeaux, France

⁴ Department of Hematology, Bergonié Institute, Bordeaux, France

⁵ Department of Hematology, Mont de Marsan Hospital, Mont de Marsan, France

⁶ Department of Hematology, Clinique Saint-Anne, Strasbourg, France

⁷ Department of Hematology, University Hospital, Dijon, France

⁸ Department of Hematology, University Hospital, Grenoble, France

⁹ Department of Hematology, Centre hospitalier Bretagne Atlantique, Vannes, France

¹⁰ Department of Biostatistics, Institut inter-régional de cancérologie, Le Mans, France

*all authors contributed equally